Yields of muscle from myogenic cells implanted into young and old mdx hosts

Muscle and Nerve

Volumn 19, Issue 2, 1996, Pages 132-139

  Morgan, Jennifer E ^a,b   Fletcher, Robert M ^a   Partridge, Terence A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

dystrophin; mdx; mouse muscle; muscle precursor cell; x irradiation

Indexed keywords

DYSTROPHIN; GLUCOSE 6 PHOSPHATE ISOMERASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STEM CELL; X IRRADIATION;

ANIMALS; HINDLIMB; MICE; MICE, INBRED C57BL; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; TIME FACTORS;

EID: 0030051129     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199602)19:2<132::AID-MUS2>3.0.CO;2-F     Document Type: Article

References (38)

1. Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991;254: 1507-1509.
2. Cardasis CA, Cooper GW: An analysis of nuclear numbers in individual muscle fibres during differentiation and growth: a satellite cell-muscle fibre growth unit. J Exp Zool 1975;191:347-358.
3. Chen M, Li H-J, Fang Q, Goodwin TG, Florendo JA, Law PK: Dystrophin cytochemistry in mdx mouse muscles injected with labelled normal myoblasts. Cell Transpl 1992;1: 17-22.
4. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM: Systemic delivery of growth hormone by injection of genetically-engineered myoblasts. Science 1991;254: 1509-1512.
5. Dimario JX, Stockdale FE: Differences in the developmental fate of cultured and noncultured myoblasts when transplanted into embryonic limbs. Exp Cell Res 1995;216: 431-142.
6. Frair PM, Peterson AC: The nuclear-cytoplasmic relationship in "mosaic" skeletal muscle fibers from mouse chimaeras. Exp Cell Res 1983;145:167-178.
7. Guerette B, Asselin I, Vilquin JT, Roy R. Tremblay JP: Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995;18: 39-51.
8. Gussoni E, Pavlath GK, Lanctot AM, Sharma KR, Miller RG, Steinman L, Blau HM: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992;356:435-138.
9. Hamamori Y, Samal B, Tian J, Kedes L: Myoblast transfer of human erythropoetin gene in a mouse model of renal failure, J Clin Invest 1995;95:1808-1813.
10. Hoffman EP: Myoblast transplantation: what's going on? Cell Transpt 1993;2:49-57.
11. Hoffman EP, Morgan JE, Watkins C, Partridge TA: Somatic reversion/suppression of the mouse mdx phenotype in vivo, J Neural Sci 1990;99:9-25.
12. Huard J, Roy R, Bouchard J-P, Malouin F, Richards CL, Trembay J-P: Human myoblast transplantation between immunohistocompatible donors and recipients products immune reactions. Transpl Proc 1992;24:3049-3051.
13. Huard J, Roy R, Guerette B, Verreault S, Tremblay G, Tremblay J-P: Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 1994;17:224-235.
14. Karpati G: Approaches to the introduction of normal allelles into skeletal muscle fibres for therapeutic purposes in Duchenne muscular dystrophy, in Kakulas BA, McHowell J. Roses AD (eds): Duchenne Muscular Dystrophy: Animal Models and Genetic Manipulation. New York, Raven Press, 1992, pp 223-236.
15. Karpati G, Pouliot Y, Zubrzycka-Gaarn E. Carpenter S, Ray PN, Worton RG, Holland P: Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989;135:27-32.
16. Karpati G, Ajdukovic D, Arnold D, Gledhill RB, Guttman R. Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M, Watters GV, Abrahamovicz M, Duff C, Worton RG: Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993;34:8-17.
17. Kinoshita I, Vilquin J-T, Guerette B, Asselin I, Roy R, Tremblay J-P: Very efficient myoblast transplantation in mice under FK 506 immunosuppression. Muscle Nerve 1994;17:1407-1415.
18. Kinoshita I, Huard J, Tremblay J-P: Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve 1994;17:975-980.
19. Law PK, Goodwin TG, Fang Q. Duggirala V, Larkin C, Florendo JA, Kirby DS, Deering MB, Li HJ, Chen M, Yoo TJ, Cornett J, Li LM, Shirzad A, Quinley T, Holcomb RL: Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transpl 1992; 1:235-244.
20. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, Nagaraja H, Stephens R, Lantry L, Morris GE, Burghes AHM: Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med, 1995;832-838.
21. Morandi L, Bernasconi P, Gebbia M, Mora M, Crosti F, Mantegazza R, Cornelio F: Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer, Neuromusc Disord 1995;5:291-295.
22. Morgan JE, Coulton GR, Partridge TA: Musde precursor cells invade and repopulate freeze-killed muscles. J Muscle Res Cell Motil 1987;8:386-396.
23. Morgan JE, Hoffman EP, Partridge TA: Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse, J Cell Biol 1990;111: 2437-2449.
24. Morgan JE, Pagel CN, Sherratt T, Partridge TA: Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci 1993; 115:191-200.
25. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
26. QuinlanJG, Lyden SP, Gambier DM, Johnson SR, Michaels SE, Denman DL: Radiation inhibition of mdx mouse muscle regeneration: dose and age factors. Muscle Nerve 1995; 18:201-206.
27. Tanaka H, Hayashi K, Ozawa E: Positive immunostaining with dystrophin antibodies in mdx skeletal muscle. P roc Japan Acad 1991;67, Ser. B:148-152.
28. Tremblay J-P, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transpl 1993;2:99-112.
29. Vilquin J-T, Asselin I, Guerette B, Kinoshita I, Roy R, Tremblay J-P: Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995;59: 422-449.
30. Wakeford S, Watt DJ, Partridge TA: X-irradiation improves mdx mouse muscle as a model or myofiber loss in DMD. Muscle Nerve 1991;14:42-50.
31. Watkins SC, Hoffman EP, Slayter HS, Kunkel LM: Dystrophin distribution in heterozygote MDX mice. Muscle Nerve 1989;12:861-868.
32. Watt DJ: Factors which affect the fusion of allogeneic muscle precursor cells in vivo. Neuropathol Appl Neurol 1982;8: 135-147.
33. Watt DJ, Lambert K, Morgan JE, Partridge TA, Sloper JC: Incorporation of donor muscle precursor cells into an area of regeneration in the host mouse, J Neurol Sci 1982;57: 319-331.
34. Watt DJ, Morgan JE, Partridge TA: Use of mononuclear precursor cells to insert allogenic genes into growing mouse muscles. Muscle Nerve 1984;7:741-750.
35. Webster C, Blau HM: Accelerated age-related decline in replicative life span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 1990;16:557-565.
36. Yao S-N, Smith KJ, Kurachi K: Primary myoblast gene transfer: persistent expression of human factor IX in mice. Gene Therapy 1994;1:99-107.
37. Zatloukal K, Gotten M, Berger M, Schmidt W, Wagner E, Birnsteil ML: In vivo production of human factor VIII in mice after intraplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Proc Natl Acad Sci USA 1994;91: 5148-5152.
38. Zhao J, Yoshioka K, Mike T, Miyatake M: Developmental studies of dystrophin-positive fibres in mdx, and DRP localization. J Neurol Sci 1993;114:104-108.